Watch ALKS. Know when insiders buy.
One email the day a filing lands. Free.
ALKS
Alkermes plc.
43.48
−0.63 −1.43%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
40
WATCH · insiders 29, shorts 51
Insiders, 90 days
−$604K
net selling · 0 buys, 3 sells
Congress, 90 days
2 / 0
buys / sells · latest disclosed Oct 12
Big money
2 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $7.3BP/E 114.4DIV YIELD —FCF YIELD 3.04%REV TTM $1.7B +10.8%NET INCOME $66.1M −81.0%NET DEBT $1B52W 27.20 – 55.22NEXT EARNINGS Oct 28 EST.SEC XBRL · TTM TO Invalid Date
Insider trading
−$604K
Net, 90 days
0 / 3
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 2 | Oct 2 | Gaffin David Joseph · EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $41.03 | $83K |
| Sep 3 | Sep 3 | Gaffin David Joseph · EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $48.01 | $98K |
| Sep 1 | Sep 1 | Hopkinson Craig C. · EVP R&D, Chief Medical Officer | Sell | 9,000 | $46.99 | $423K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.